National and Kapodistrian University of Athens
Μέτρηση επιπέδων 8 - ισοπροστάνης στο συμπύκνωμα εκπνεόμενου αέρα και στον ορό ασθενών με μη μικροκυτταρικό καρκίνο του πνεύμονα (NSCLC), πριν και μετά το πέρας της χημειοθεραπείας: συσχέτιση με κλινικές και παθολογοανατομικές παραμέτρους
Abstract
dc:descriptionBackground – Aim of the study: Lung cancer is the leading cause of global cancer death with oxidative stress playing a significant role in its pathogenesis. 8-isoprostane is an established biomarker of oxidative stress that is significantly involved in lung cancer pathogenesis. Aim of the current study is to evaluate the effect of chemotherapy at the levels of oxidative stress as expressed through the measurement of 8-isoprostane in Exhaled Breath Condensate (EBC) and serum levels of patients with Non Small Cell Lung Cancer (NSCLC). Moreover correlations with both clinical and pathology parameters were evaluated.Patients and Methods: Forty five (45) patients with inoperable non-small cell lung cancer were initially enrolled in this study and twenty nine (29) of them were finally evaluated in regards to 8-isoprostane levels in EBC and serum before and after chemotherapy (after completion of 6 cycles of chemotherapy) respectively and in correlation with the extent of the disease and response to chemotherapy. Moreover thirty healthy volunteers were also enrolled as controls.Results: 8-isoprostane serum levels were statistically significant lower after chemotherapy in both EBC and serum (p=0.014 and p= 0.05 respectively). Further analysis showed that the above differences were mainly attributed to the extent of the disease, as well as to the response to treatment. More specifically patients diagnosed with limited / locally advanced disease (stages IB – IIIB) presented with post chemotherapy EBC and serum 8 - isoprostane levels statistically significant lower (p=0.031 and p=0.09 respectively) , furthermore patients evaluated with partial response (PR) after chemotherapy also presented statistically significant lower EBC and serum 8 –isoprostane levels ( p=0.02 and p= 0.07).Conclusion: In this prospective study - with the limitation in the number of patients - we showed that 8-isoprostane might represent a biomarker in NSCLC sharing properties of response to chemotherapy as well as to the extent of the disease.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stathopoulos, Dimitrios
- Σταθόπουλος, Δημήτριος
Subjects
dc:subject × 14Rights
dc:rights- Statement dc:rights
-
- BY_NC_SA
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42453